Cargando…

Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis

BACKGROUND: Pathogenic inflammatory pathways are largely shared between different autoimmune and inflammatory diseases (AIDs). This offers the potential to develop a given targeted therapy in several AIDs. METHODS: We analyzed two clinical trials registries (ClinicalTrials.gov and EU Clinical Trials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petitdemange, Arthur, Blaess, Julien, Sibilia, Jean, Felten, Renaud, Arnaud, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747103/ https://www.ncbi.nlm.nih.gov/pubmed/33403021 http://dx.doi.org/10.1177/1759720X20969261

Ejemplares similares

Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage
por: Blaess, Julien, et al.
Publicado: (2020)

Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey
por: Petitdemange, Arthur, et al.
Publicado: (2021)

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study
por: Scherlinger, Marc, et al.
Publicado: (2021)

Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic
por: Scherlinger, Marc, et al.
Publicado: (2022)

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France
por: Felten, Renaud, et al.
Publicado: (2021)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials
por: Denis, Agathe, et al.
Publicado: (2023)

Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
por: Felten, Renaud, et al.
Publicado: (2022)

How and why are rheumatologists relevant to COVID-19?
por: Felten, Renaud, et al.
Publicado: (2020)

Comment et pourquoi les rhumatologues sont importants face à la crise du COVID-19 ?()
por: Felten, Renaud, et al.
Publicado: (2020)

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2022)

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab
por: Felten, Renaud, et al.
Publicado: (2022)

Genome Target Evaluator (GTEvaluator): A workflow exploiting genome dataset to measure the sensitivity and specificity of genetic markers
por: Felten, Arnaud, et al.
Publicado: (2017)

Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
por: Fender, Anke C., et al.
Publicado: (2020)

Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
por: Blaess, Markus, et al.
Publicado: (2020)

Biocomputing drug repurposing toward targeted therapies
por: Cardone, Luca
Publicado: (2016)

Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date
por: Felten, Renaud, et al.
Publicado: (2019)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)

Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease
por: Spitschak, Alf, et al.
Publicado: (2022)

Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases: Perspectives and therapeutic aspects
por: Harifi, Ghita, et al.
Publicado: (2016)

Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases
por: Municio, Cristina, et al.
Publicado: (2021)

Repurposing a Drug Targeting Inflammatory Bowel Disease for Lowering Hypertension
por: Mei, Xue, et al.
Publicado: (2022)

Effet de la vaccination anti-SARS-CoV-2 sur les symptômes prolongés post-Covid : résultat de l’enquête nationale VAXILONG
por: Scherlinger, M., et al.
Publicado: (2021)

Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing
por: Ortiz-Fernández, Lourdes, et al.
Publicado: (2023)

Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review
por: Sweiti, Hussein, et al.
Publicado: (2017)

B cell targeted therapies in inflammatory autoimmune disease of the central nervous system
por: Furman, Moritz J., et al.
Publicado: (2023)

Repurposing Thioridazine (TDZ) as an anti-inflammatory agent
por: Baig, Mirza S., et al.
Publicado: (2018)

Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)

Repurposing immunosuppressants for antileukemia therapy
por: Sezaki, Maiko, et al.
Publicado: (2022)

Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing
por: Burchett, Jason R., et al.
Publicado: (2022)

Pruritus in Autoimmune and Inflammatory Dermatoses
por: Zeidler, Claudia, et al.
Publicado: (2019)

Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity
por: Scherlinger, Marc, et al.
Publicado: (2023)

An OpenData portal to share COVID-19 drug repurposing data in real time
por: Brimacombe, Kyle R., et al.
Publicado: (2020)

Repurposing drugs to target nonalcoholic steatohepatitis
por: Sookoian, Silvia, et al.
Publicado: (2019)

Repurposing Canagliflozin to target brain aging
por: Jayarathne, Hashan, et al.
Publicado: (2023)

Systematically exploring repurposing effects of antihypertensives
por: Shahn, Zach, et al.
Publicado: (2022)

In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax
por: Martchenko Shilman, Mikhail, et al.
Publicado: (2021)

Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?
por: Kohle, Felix, et al.
Publicado: (2023)

Against Repurposing Methadone for Glioblastoma Therapy
por: Vatter, Tatjana, et al.
Publicado: (2020)

Repurposing approved drugs for cancer therapy
por: Schein, Catherine H
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7je8d4tcjsl5jsp9qtock9t1s